Albanian Berg Balance Scale
Launched by UNIVERSIDAD CATÓLICA SAN ANTONIO DE MURCIA · Feb 13, 2025
Trial Information
Current as of September 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Albanian Berg Balance Scale trial is a study that aims to adapt and test a balance assessment tool called the Berg Balance Scale specifically for the Albanian population. This tool helps evaluate how well older adults can maintain their balance and control their movements. The goal is to ensure that the scale is both reliable and valid for use in Albania, which means it should provide accurate results for the people in this country.
To participate in this trial, individuals aged between 18 and 29 who experience postural pain or muscle contractions may be eligible. However, those with certain conditions like fractures, trauma, dislocations, or tumors will not be able to join. If selected, participants can expect to take part in assessments that measure their balance. It’s important to note that this trial is not yet recruiting participants, so there will be more details available in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Postural pain
- • muscular contractions
- Exclusion Criteria:
- • mixed fractures
- • trauma
- • luxation
- • tumor
About Universidad Católica San Antonio De Murcia
Universidad Católica San Antonio de Murcia (UCAM) is a prominent academic institution in Spain, dedicated to advancing research and innovation in the healthcare sector. With a strong emphasis on interdisciplinary collaboration, UCAM sponsors clinical trials that aim to enhance medical knowledge and improve patient outcomes. The university fosters a research-driven environment, leveraging its state-of-the-art facilities and expert faculty to conduct rigorous scientific investigations. UCAM is committed to upholding the highest ethical standards in clinical research, ensuring the safety and well-being of participants while contributing valuable insights to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported